Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)

被引：0
|
作者：
Kirsten C. Morley
Henry R. Kranzler
Natasha Luquin
Andrew Baillie
Marian Shanahan
Ronald Trent
Maree Teesson
Paul S. Haber
机构：
[1] University of Sydney,Faculty of Medicine and Health, Health Sciences NHMRC Centre of Research Excellence in Mental Health and Substance Use
[2] Faculty of Medicine and Health,undefined
[3] Central Clinical School,undefined
[4] NHMRC Centre of Research Excellence in Mental Health and Substance Use,undefined
[5] Center for Studies of Addiction,undefined
[6] Perelman School of Medicine,undefined
[7] University of Pennsylvania and Mental Illness Research,undefined
[8] Education,undefined
[9] and Clinical Center,undefined
[10] Crescenz VAMC,undefined
[11] Department of Medical Genomics,undefined
[12] Royal Prince Alfred Hospital,undefined
[13] University of Sydney,undefined
[14] National Drug and Alcohol Research Centre,undefined
[15] UNSW,undefined
[16] NHMRC Centre of Research Excellence in Mental Health and Substance Use,undefined
[17] National Drug and Alcohol Research Centre,undefined
[18] UNSW,undefined
[19] Drug Health Services,undefined
[20] Royal Prince Alfred Hospital,undefined
来源：
Trials | / 19卷
关键词：
Topiramate; Alcohol use disorder; Pharmacogenetics; Naltrexone; Alcohol dependence; GRIK1; OPRM1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
    Morley, Kirsten C.
    Kranzler, Henry R.
    Luquin, Natasha
    Baillie, Andrew
    Shanahan, Marian
    Trent, Ronald
    Teesson, Maree
    Haber, Paul S.
    TRIALS, 2018, 19
  • [2] Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial
    Morley, Kirsten C.
    Kranzler, Henry R.
    Luquin, Natasha
    Jamshidi, Nazila
    Adams, Claire
    Montebello, Mark
    Tremonti, Chris
    Dali, Gezelle
    Logge, Warren
    Baillie, Andrew
    Teesson, Maree
    Trent, Ronald
    Haber, Paul S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2024, 181 (05): : 403 - 411
  • [3] Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial (vol 181, pg 403, 2024)
    Morley, Kirsten C.
    AMERICAN JOURNAL OF PSYCHIATRY, 2024, 181 (08): : 775 - 775
  • [4] Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
    Martinotti, G.
    Di Nicola, M.
    Tedeschi, D.
    Andreoli, S.
    Reina, D.
    Pomponi, M.
    Mazza, M.
    Romanelli, R.
    Moroni, N.
    De Filippis, R.
    Di Giannantonio, M.
    Pozzi, G.
    Bria, P.
    Janiri, L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (09) : 1367 - 1374
  • [5] The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial
    Hurzeler, Tristan P.
    Logge, Warren
    Watt, Joshua
    DeMayo, Marilena M.
    Suraev, Anastasia
    McGregor, Iain S.
    Haber, Paul S.
    Morley, Kirsten C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 41
  • [6] Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
    D. Mei
    A. Capuano
    C. Vollono
    M. Evangelista
    D. Ferraro
    P. Tonali
    G. Di Trapani
    Neurological Sciences, 2004, 25 : 245 - 250
  • [7] Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
    Mei, D
    Capuano, A
    Vollono, C
    Evangelista, M
    Ferraro, D
    Tonali, P
    Di Trapani, G
    NEUROLOGICAL SCIENCES, 2004, 25 (05) : 245 - 250
  • [8] Topiramate versus propranolol for prevention of chronic migraine: A randomized double-blind controlled trial (TOP-PRO study)
    Chowdhury, Debashish
    Bansal, Luv
    Duggal, Ashish
    Datta, Debabrata
    Koul, Arun
    Mundra, Ankit
    Krishnan, Anand
    Gupta, Anu
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [9] TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine
    Chowdhury, Debashish
    Bansal, Luv
    Duggal, Ashish
    Datta, Debabrata
    Mundra, Ankit
    Krishnan, Anand
    Koul, Arun
    Gupta, Anu
    CEPHALALGIA, 2022, 42 (4-5) : 396 - 408
  • [10] A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
    Mcketin, Rebecca
    Degan, Tayla J.
    Saunders, Lucy
    Nguyen, Long
    Dore, Gregory
    Shoptaw, Steven
    Farrell, Michael
    Degenhardt, Louisa
    Kelly, Peter J.
    Turner, Alyna
    Clare, Philip J.
    Dean, Olivia M.
    Arunogiri, Shalini
    Colledge-Frisby, Samantha
    Koeijers, Juanita
    Goodman-Meza, David
    Sinclair, Barbara
    Reid, David
    Hill, Harry
    Hayllar, Jeremy
    Christmass, Michael
    Cordaro, Frank
    Lundin, Robert
    Liaw, Willy
    Liu, Danica
    Holyoak, Ellie
    Wu, Brian Tid-Fung
    Keygan, Joel
    Kontogiannis, Ava
    Palmer, Lily
    Morrison, Caity
    Wrobel, Anna
    Hyland, Bec
    Byrne, Marianne
    Russell, Samantha
    Zahra, Emma
    Berk, Michael
    TRIALS, 2024, 25 (01)
12345